Mirikizumab (Omvoh) is effective in inducing a clinical response in adults with moderate-to-severe ulcerative colitis and ...

A variant of the Aeromonas bacterium promoted colon inflammation in mice and was detected in stools and colon tissue from ...

The discovery that a toxin made by bacteria found in dirty water might help trigger ulcerative colitis could lead to new ...

Aeromonas, toxic bacteria, may by kill body’s defensive immune cells, causing ulcerative colitis (inflammatory bowel disease) ...

Interleukin-23 (IL-23) plays a pivotal role in the complex pathogenesis of both ulcerative colitis and Crohn's disease, making it a promising therapeutic target.1 Mirikizumab is a humanised IgG4 ...

A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal ...

Johnson & Johnson Pvt. Ltd. (JnJ) has been asked to justify key aspects of its proposed Phase III clinical trial protocol for ...

AnaptysBio (ANAB) just revealed that its Phase 2 trial for rosnilimab in moderate-to-severe ulcerative colitis is being discontinued because the treatment did not outperform placebo in reaching ...

A toxin-secreting gut bacterium may fuel ulcerative colitis by killing protective immune cells that maintain intestinal homeostasis, according to a ...

Chinese scientists may have developed a possible alternative to colonoscopies for detecting gastrointestinal diseases with a ...

Market opportunities in the IBD treatment sector include the rising demand for targeted therapies and biologics due to a deeper understanding of the disease, alongside the expansion of biosimilar ...